David Miller

Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial

Richard E. Thompson, Michael Rosenblum, Gayane Yenokyan et al. · The Lancet · 2019 · 899 citations · Full text

Medicine, Neurosurgery, Surgery +15

The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma

Veit J. Erpenbeck, Todor A. Popov, David Miller et al. · Pulmonary Pharmacology & Therapeutics · 2016 · 109 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial

Antonio Uccelli, Alice Laroni, Rehiana Ali et al. · The Lancet Neurology · 2021 · 109 citations

Life Sciences, Neurology, Neuroscience +15

Effect of sharp debridement using curette on recalcitrant nonhealing venous leg ulcers: A concurrently controlled, prospective cohort study

Dean Williams, Stuart Enoch, David Miller et al. · Wound Repair and Regeneration · 2005 · 104 citations · Full text

Nursing, Surgery, Vascular Surgery +15

Emergency Medical Services Outcomes Project (EMSOP) II: Developing the foundation and conceptual models for out-of-hospital outcomes research

Daniel W. Spaite, Ronald F. Maio, Herbert G. Garrison et al. · Annals of Emergency Medicine · 2001 · 86 citations · Full text

Public Affairs, Emergency Medical Services, Emergency Medicine +12